drugset / Trial / NCT06493084
Evaluate LAE102 in Healthy and Overweight/Obese Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE102 injection in healthy and overweight/obese participants, and also evaluate the preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants.
Timeline
- Start
- 2024-06-25
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAE102 | Unknown | — | Intravenous |
Indications
No indication recorded.